Multiple endocrine neoplasia type 1 with MEN1 gene mutation: A clinical case report

  • Pham Thi Hong Nhung 108 Military Central Hospital

Main Article Content

Keywords

Multiple endocrine neoplasia type 1, parathyroid glands, pituitary adenoma, pancreatic neuroendocrine tumor

Abstract

Multiple endocrine neoplasia type 1 is a rare syndrome, defined as the existence of at least 2 of the 3 main tumor types: Pituitary adenoma, parathyroid glands and pancreatic islets. In addition to the above tumors, patients may have tumors in other locations such as adrenal tumors, thymus tumors, esophageal tumors, stomach tumors... This syndrome is easy to miss due to the presence of many tumors, patients can be detected in many different clinical departments. We describe our experience in the diagnosis and management of a case of multiple endocrine neoplasia type 1. Clinical case of a 56-year-old female patient admitted to the hospital because of a large pituitary adenoma; The patient continued to have other tumors detected: Surgical neck tumor with primary hyperparathyroidism, pancreatic neuroendocrine tumor, bilateral adrenal adenoma, liver tumor. The patient's genetic testing results identified a pathogenic mutation on the MEN1 gene on chromosome 11 (autosomal dominant). Finally, the patient was successfully treated with neuroendocrine pancreatic tumor surgery, left adrenalectomy, and medical treatment.

Article Details

References

1. Romei C, Pardi E, Cetani F et al (2012) Genetic and clinical features of multiple endocrine neoplasia types 1 and 2. J Oncol 705036.
2. Thakker RV (1998) Multiple endocrine neoplasia syndromes of the twentieth century. J Clin Endocrinol Metab 83(8): 2617-2620.
3. Singh G, Mulji NJ, Jialal I (2023) Multiple endocrine neoplasia type 1. statpearls. StatPearls Publishing, Treasure Island (FL).
4. Thakker RV, Newey PJ, Walls GV et al (2012) Clinical Practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97(9): 2990-3011.
5. Langer P, Cupisti K, Bartsch DK et al (2002) Adrenal involvement in multiple endocrine neoplasia type 1. World J Surg 26(8): 891-896.
6. Wang W, Han R, Ye L et al (2019) Adrenocortical carcinoma in patients with MEN1: A kindred report and review of the literature. Endocr Connect 8(3): 230-238.
7. Ranaweerage R, Perera S, Sathischandra H (2022) Occult insulinoma with treatment refractory, severe hypoglycaemia in multiple endocrine neoplasia type 1 syndrome; difficulties faced during diagnosis, localization and management; a case report. BMC Endocr Disord 22(1): 68.
8. Wang Y, Zhang H (2021) Multiple endocrine neoplasia type 1 with refractory hypoglycemia and lung and liver metastases: A case report. J Int Med Res 49(1): 0300060520961682.
9. Johnston ME, Carter MM, Wilson GC et al (2020) Surgical management of primary pancreatic neuroendocrine tumors. J Gastrointest Oncol 11(3): 578-589.
10. Debillon E, Velayoudom-Cephise FL, Salenave S et al (2015) Unilateral adrenalectomy as a first-line treatment of cushing’s syndrome in patients with primary bilateral macronodular adrenal hyperplasia. J Clin Endocrinol Metab 100(12): 4417-4424.
11. Araujo-Castro M, Reincke M (2023) Primary bilateral macronodular adrenal hyperplasia: A series of 32 cases and literature review. Endocrinol Diabetes Nutr 70(4): 229-239.
12. Nell S, Borel Rinkes IHM, Verkooijen HM et al (2018) Early and late complications after surgery for MEN1-related nonfunctioning pancreatic neuroendocrine tumors. Ann Surg 267(2): 352-356.